Illumina Inc
(BSP:I1LM34)
R$
121.72
0 (0%)
Market Cap: 96.95 Bil
Enterprise Value: 103.35 Bil
PE Ratio: 0
PB Ratio: 3.01
GF Score: 66/100 - Q1 2024 Illumina Inc Earnings Call TranscriptMay 02, 2024R$128.41Earnings
- Q4 2023 Illumina Inc Earnings Call TranscriptFeb 08, 2024R$143.16Earnings
- Illumina Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Illumina Inc at Piper Sandler Healthcare Conference TranscriptNov 29, 2023
- Illumina Inc at Evercore ISI HealthCONx Conference TranscriptNov 28, 2023
- Q3 2023 Illumina Inc Earnings Call TranscriptNov 09, 2023R$106.77Earnings
- Illumina Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Illumina Inc at UBS Genomics 2.0 and MedTech Innovations Summit TranscriptAug 17, 2023
- Q2 2023 Illumina Inc Earnings Call TranscriptAug 09, 2023R$181.19Earnings
- Illumina Inc To Host Third Annual Virtual ESG Investor Event TranscriptJun 12, 2023
- Q1 2023 Illumina Inc Earnings Call TranscriptApr 25, 2023R$221.2Earnings
- Illumina Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- Q4 2022 Illumina Inc Earnings Call TranscriptFeb 07, 2023R$217.69Earnings
- Illumina Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Illumina Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Illumina Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 Illumina Inc Earnings Call TranscriptNov 03, 2022R$216.83 (-4.29%)Earnings
- Illumina Inc To Host Second Annual Virtual ESG Investor Event TranscriptOct 28, 2022
- Illumina Inc 2022 Investor Day TranscriptOct 03, 2022
- Illumina Inc Innovation Roadmap Session - Corporate Call TranscriptSep 29, 2022
- Q2 2022 Illumina Inc Earnings Call TranscriptAug 11, 2022R$233.45 (+1.37%)Earnings
- Illumina Inc at Bank of America Healthcare Conference TranscriptMay 12, 2022
- Q1 2022 Illumina Inc Earnings Call TranscriptMay 05, 2022R$289.93 (-4.65%)Earnings
- Illumina Inc at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Illumina Inc at Citi Healthcare Conference (Virtual) TranscriptFeb 24, 2022
- Illumina Inc at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 17, 2022
- Q4 2021 Illumina Inc Earnings Call TranscriptFeb 10, 2022R$376.62 (-1.76%)Earnings
- Illumina Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2022
- Illumina Inc Inaugural ESG Investor Event TranscriptNov 16, 2021
- Q3 2021 Illumina Inc Earnings Call TranscriptNov 04, 2021R$474.47 (+1.40%)Earnings
- Illumina Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Illumina Inc Acquires Grail Inc Call TranscriptAug 18, 2021
- Illumina Inc at UBS Genomics 2.0 and MedTech Innovations Summit TranscriptAug 11, 2021
- Q2 2021 Illumina Inc Earnings Call TranscriptAug 05, 2021R$536.64 (+2.65%)Earnings
- Illumina Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2021
- Illumina Inc Annual Shareholders Meeting TranscriptMay 26, 2021
- Illumina Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Illumina Inc Earnings Call TranscriptApr 27, 2021R$456.6 (+0.07%)Earnings
- Illumina Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Illumina Inc at SVB Leerink Global Healthcare Conference (Virtual) TranscriptFeb 25, 2021
- Q4 2020 Illumina Inc Earnings Call TranscriptFeb 11, 2021R$487.5 (-0.20%)Earnings
- Illumina Inc at JPMorgan Healthcare Conference (Virtual) and Q&A Session TranscriptJan 11, 2021
- Illumina Inc at Piper Sandler Healthcare Conference (Virtual) TranscriptDec 03, 2020
- Q3 2020 Illumina Inc Earnings Call TranscriptOct 29, 2020R$363.61 (+1.28%)Earnings
- Illumina Inc at Cowen Liquid Biopsy Summit (Virtual) TranscriptSep 24, 2020
- Illumina Inc to Acquire GRAIL - M&A Call TranscriptSep 21, 2020
- Illumina Inc at UBS Genomics 2.0 and Medtech Innovations Summit (Virtual) TranscriptAug 12, 2020
- Q2 2020 Illumina Inc Earnings Call TranscriptAug 06, 2020R$399Earnings
- Illumina Inc Annual Shareholders Meeting TranscriptMay 27, 2020
- Q1 2020 Illumina Inc Earnings Call TranscriptApr 30, 2020R$251.22Earnings
- Illumina Inc at Cowen HealthCare Conference TranscriptMar 03, 2020
- Illumina Inc at Leerink Global Healthcare Conference TranscriptFeb 26, 2020
- Q4 2019 Illumina Inc Earnings Call TranscriptJan 29, 2020Earnings
- Illumina Inc at JPMorgan Healthcare Conference - Presentation TranscriptJan 13, 2020
- Illumina Inc at Piper Jaffray Healthcare Conference TranscriptDec 05, 2019
- Illumina Inc at Evercore HealthCONx Conference TranscriptDec 04, 2019
- Q3 2019 Illumina Inc Earnings Call TranscriptOct 24, 2019Earnings
- Q2 2019 Illumina Inc Earnings Call TranscriptJul 29, 2019Earnings
- Illumina Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Illumina Inc Annual Shareholders Meeting TranscriptMay 29, 2019
- Illumina Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 15, 2019
- Q1 2019 Illumina Inc Earnings Call TranscriptApr 25, 2019Earnings
- Illumina Inc at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Q4 2018 Illumina Inc Earnings Call TranscriptJan 29, 2019Earnings
Illumina Inc at UBS Genomics 2.0 and Medtech Innovations Summit (Virtual) Transcript
Aug 12, 2020 / 05:00PM GMT
Release Date Price:
R$386.99
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Welcome to the day 2 of the conference.
Sorry for the lack of video. There was a power outage with our supplier. Hopefully, we'll get it rectified here shortly. So unfortunately, we're going to have audio only. But certainly, I don't think it will lack any of the content that will be coming through. Really pleased to be joined by Francis deSouza, President and CEO, obviously, of Illumina. Illumina has been the key anchor tenant here since the conference was started, I don't know, 6 or 7 years ago.
So Francis, we certainly appreciate your being with us today and giving us your time.
Francis A. deSouza
Illumina, Inc. - CEO, President & Director
Thank you, Dan, for having me.
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Terrific. I think you may wanted to read the safe harbor statement before we
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)